1. Home
  2. HYPR vs ICCC Comparison

HYPR vs ICCC Comparison

Compare HYPR & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$0.78

Market Cap

83.2M

Sector

Health Care

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.13

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYPR
ICCC
Founded
2014
1982
Country
United States
United States
Employees
102
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.2M
93.1M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
HYPR
ICCC
Price
$0.78
$10.13
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$1.59
N/A
AVG Volume (30 Days)
368.3K
14.7K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
23.21
53.85
EPS
N/A
0.41
Revenue
$13,563,000.00
$26,493,169.00
Revenue This Year
$50.75
N/A
Revenue Next Year
$29.71
N/A
P/E Ratio
N/A
$24.29
Revenue Growth
5.22
51.64
52 Week Low
$0.76
$4.52
52 Week High
$2.22
$12.10

Technical Indicators

Market Signals
Indicator
HYPR
ICCC
Relative Strength Index (RSI) 33.22 47.04
Support Level N/A $9.27
Resistance Level $1.39 $10.75
Average True Range (ATR) 0.03 0.26
MACD 0.00 0.04
Stochastic Oscillator 33.33 66.43

Price Performance

Historical Comparison
HYPR
ICCC

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: